Estimates of insulin sensitivity from the intravenous-glucose-modified-clamp test depend on suppression of lipolysis in type 2 diabetes: A randomised controlled trial

Diabetologia

Volumn 57, Issue 10, 2014, Pages 2094-2102

  Kahl, Sabine ^a,b   Nowotny, Bettina ^a,b   Piepel, Simon ^a   Nowotny, Peter J ^a,b   Strassburger, Klaus ^a,b   Herder, Christian ^a,b   Pacini, Giovanni ^c   Roden, Michael ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^c CNR   (Italy)

Author keywords

Glucose transport; Insulin resistance; Insulin sensitivity; Lipid metabolism; Metabolic physiology

Indexed keywords

C PEPTIDE; CYTOKINE; FATTY ACID; GLUCOSE; METFORMIN; PLACEBO; GLUCOSE BLOOD LEVEL; INSULIN;

ADULT; AGED; ARTICLE; CALORIMETRY; CLINICAL ARTICLE; CLINICAL RESEARCH; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET; ENERGY EXPENDITURE; FAT FREE MASS; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE OXIDATION; HUMAN; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE MODIFIED CLAMP TEST; LIPID OXIDATION; LIPOLYSIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TISSUE SPECIFICITY; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; INSULIN RESISTANCE; MASS FRAGMENTOGRAPHY; METABOLISM; MIDDLE AGED;

ADULT; BLOOD GLUCOSE; CALORIMETRY, INDIRECT; DIABETES MELLITUS, TYPE 2; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPOLYSIS; MALE; MIDDLE AGED;

EID: 84926626604     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3328-3     Document Type: Article

References (50)

1. Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787–794
2. Defronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223
3. Roden M (2007) Clinical diabetes research – methods and techniques. Wiley, Chichester
4. Lehto M, Tuomi T, Mahtani MM et al (1997) Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect. J Clin Invest 99:582–591
5. Stancakova A, Pihlajamaki J, Kuusisto J et al (2008) Single-nucleotide polymorphism rs7754840 of CDKAL1 is associated with impaired insulin secretion in nondiabetic offspring of type 2 diabetic subjects and in a large sample of men with normal glucose tolerance. J Clin Endocrinol Metab 93:1924–1930
6. Tripathy D, Wessman Y, Gullstrom M, Tuomi T, Groop L (2003) Importance of obtaining independent measures of insulin secretion and insulin sensitivity during the same test: results with the Botnia clamp. Diabetes Care 26:1395–1401
7. Perseghin G, Ghosh S, Gerow K, Shulman GI (1997) Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes 46:1001–1009
8. Mari A, Tura A, Natali A et al (2011) Influence of hyperinsulinemia and insulin resistance on in vivo beta-cell function: their role in human beta-cell dysfunction. Diabetes 60:3141–3147
9. Defronzo RA (2004) Pathogenesis of type 2 diabetes mellitus. Med Clin N Am 88:787–835
10. Roden M, Price TB, Perseghin G et al (1996) Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97:2859–2865
11. Stefan N, Stumvoll M, Bogardus C, Tataranni PA (2003) Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT. Am J Physiol Endocrinol Metab 284:E1156–E1161
12. Iozzo P, Lautamaki R, Geisler F et al (2004) Non-esterified fatty acids impair insulin-mediated glucose uptake and disposition in the liver. Diabetologia 47:1149–1156
13. Ahren B, Thorsson O (2003) Increased insulin sensitivity is associated with reduced insulin and glucagon secretion and increased insulin clearance in man. J Clin Endocrinol Metab 88:1264–1270
14. Rizza RA, Mandarino LJ, Gerich JE (1982) Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab 54:131–138
15. Roden M, Stingl H, Chandramouli Vet al (2000) Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes 49:701–707
16. Le RD, Zick Y (2001) Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care 24:588–597
17. Bansal P, Wang Q (2008) Insulin as a physiological modulator of glucagon secretion. Am J Physiol Endocrinol Metab 295:E751–E761
18. Iranmanesh A, Lawson D, Dunn B, Veldhuis JD (2011) Glucose ingestion selectively amplifies ACTH and cortisol secretory-burst mass and enhances their joint synchrony in healthy men. J Clin Endocrinol Metab 96:2882–2888
19. Esposito K, Nappo F, Marfella R et al (2002) Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106:2067–2072
20. Ceriello A, Assaloni R, Da RR et al (2005) Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. Circulation 111:2518–2524
21. Kempf K, Rose B, Herder C, Kleophas U, Martin S, Kolb H (2006) Inflammation in metabolic syndrome and type 2 diabetes: impact of dietary glucose. Ann N Y Acad Sci 1084:30–48
22. Hotamisligil GS (1999) The role of TNFalpha and TNF receptors in obesity and insulin resistance. J Intern Med 245:621–625
23. Herder C, Brunner EJ, Rathmann W et al (2009) Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study. Diabetes Care 32: 421–423
24. Sartipy P, Loskutoff DJ (2003) Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A 100: 7265–7270
25. Shoelson SE, Herrero L, Naaz A (2007) Obesity, inflammation, and insulin resistance. Gastroenterology 132:2169–2180
26. Anonymous (2012) Standards of medical care in diabetes–2012. Diabetes Care 35(Suppl 1):S11–S63
27. Schmid AI, Szendroedi J, Chmelik M, Krssak M, Moser E, Roden M (2011) Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes. Diabetes Care 34:448–453
28. Segal KR, Van LM, Fitzgerald PI, Hodgdon JA, Van Itallie TB (1988) Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study. Am J Clin Nutr 47:7–14
29. Szendroedi J, Anderwald C, Krssak M et al (2009) Effects of high-dose simvastatin therapy on glucose metabolism and ectopic lipid deposition in nonobese type 2 diabetic patients. Diabetes Care 32: 209–214
30. Weickert MO, Loeffelholz CV, Roden M et al (2007) A Thr94Ala mutation in human liver fatty acid-binding protein contributes to reduced hepatic glycogenolysis and blunted elevation of plasma glucose levels in lipid-exposed subjects. Am J Physiol Endocrinol Metab 293:E1078–E1084
31. Schadewaldt P, Nowotny B, Strassburger K, Kotzka J, Roden M (2013) Indirect calorimetry in humans: a postcalorimetric evaluation procedure for correction of metabolic monitor variability. Am J Clin Nutr 97:763–773
32. Frayn KN (1983) Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55:628–634
33. Nowotny B, Nowotny PJ, Strassburger K, Roden M (2012) Precision and accuracy of blood glucose measurements using three different instruments. Diabet Med 29:260–265
34. Herder C, Schneitler S, Rathmann W et al (2007) Low-grade inflammation, obesity, and insulin resistance in adolescents. J Clin Endocrinol Metab 92:4569–4574
35. Krebs M, Krssak M, Nowotny P et al (2001) Free fatty acids inhibit the glucose-stimulated increase of intramuscular glucose-6-phosphate concentration in humans. J Clin Endocrinol Metab 86: 2153–2160
36. Tura A, Sbrignadello S, Succurro E, Groop L, Sesti G, Pacini G (2010) An empirical index of insulin sensitivity from short IVGTT: validation against the minimal model and glucose clamp indices in patients with different clinical characteristics. Diabetologia 53:144–152
37. Nowotny B, Zahiragic L, Krog D et al (2013) Mechanisms underlying the onset of oral lipid-induced skeletal muscle insulin resistance in humans. Diabetes 62:2240–2248
38. Mari A, Stojanovska L, Proietto J, Thorburn AW (2003) A circulatory model for calculating non-steady-state glucose fluxes. Validation and comparison with compartmental models. Comput Methods Prog Biomed 71:269–281
39. Morbiducci U, Di BG, Kautzky-Willer A, Deriu MA, Pacini G, Tura A (2011) Identification of a model of non-esterified fatty acids dynam ics through genetic algorithms: the case of women with a history of gestational diabetes. Comput Biol Med 41:146–153
40. Tam CS, Xie W, Johnson WD, Cefalu WT, Redman LM, Ravussin E (2012) Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care 35:1605–1610
41. Bush NC, Basu R, Rizza RA, Nair KS, Khosla S, Jensen MD (2012) Insulin-mediated FFA suppression is associated with triglyceridemia and insulin sensitivity independent of adiposity. J Clin Endocrinol Metab 97:4130–4138
42. Szendroedi J, Schmid AI, Chmelik M et al (2007) Muscle mitochon-drial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes. PLoS Med 4:e154
43. Samuel VT, Petersen KF, Shulman GI (2010) Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375:2267–2277
44. Jornayvaz FR, Shulman GI (2012) Diacylglycerol activation of protein kinase Cepsilon and hepatic insulin resistance. Cell Metab 15: 574–584
45. Bikman BT, Summers SA (2011) Ceramides as modulators of cellular and whole-body metabolism. J Clin Invest 121:4222–4230
46. Santomauro AT, Boden G, Silva ME et al (1999) Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 48:1836–1841
47. Galgani JE, Moro C, Ravussin E (2008) Metabolic flexibility and insulin resistance. Am J Physiol Endocrinol Metab 295:E1009– E1017
48. Roden M, Perseghin G, Petersen KF et al (1996) The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans. J Clin Invest 97:642–648
49. Moore MC, Satake S, Baranowski B, Hsieh PS, Neal DW, Cherrington AD (2002) Effect of hepatic denervation on peripheral insulin sensitivity in conscious dogs. Am J Physiol Endocrinol Metab 282:E286–E296
50. Tonelli J, Kishore P, Lee DE, Hawkins M (2005) The regulation of glucose effectiveness: how glucose modulates its own production. Curr Opin Clin Nutr Metab Care 8:450–456